These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 17604932

  • 1. Superselective intra-arterial infusion chemotherapy for stage III/IV squamous cell carcinomas of the oral cavity: midterm results.
    Ikushima I, Korogi Y, Ishii A, Hirai T, Yamura M, Nishimura R, Baba Y, Yamashita Y, Shinohara M.
    Eur J Radiol; 2008 Apr; 66(1):7-12. PubMed ID: 17604932
    [Abstract] [Full Text] [Related]

  • 2. Superselective arterial infusion chemotherapy for squamous cell carcinomas of the oral cavity: histopathologic effects on metastatic neck lymph nodes.
    Ikushima I, Korogi Y, Ishii A, Hirai T, Yamura M, Nishimura R, Baba Y, Yamashita Y, Shinohara M.
    Eur Arch Otorhinolaryngol; 2007 Mar; 264(3):269-75. PubMed ID: 17061084
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Intra-arterial infusion chemotherapy using cisplatin with radiotherapy for Stage III squamous cell carcinoma of the cervix.
    Kaneyasu Y, Nagai N, Nagata Y, Hashimoto Y, Yuki S, Murakami Y, Kenjo M, Kakizawa H, Toyota N, Fujiwara H, Kudo Y, Ito K.
    Int J Radiat Oncol Biol Phys; 2009 Oct 01; 75(2):369-77. PubMed ID: 19735865
    [Abstract] [Full Text] [Related]

  • 5. Retrospective analysis on prognostic impact of adjuvant chemotherapy in the patients with advanced and resectable oral squamous cell carcinoma.
    Kurita H, Koike T, Miyazawa H, Uehara S, Kobayashi H, Kurashina K.
    Gan To Kagaku Ryoho; 2006 Jul 01; 33(7):915-21. PubMed ID: 16835480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pretreatment probability model for predicting outcome after intraarterial chemoradiation for advanced head and neck carcinoma.
    van den Broek GB, Rasch CR, Pameijer FA, Peter E, van den Brekel MW, Tan IB, Schornagel JH, de Bois JA, Zijp LJ, Balm AJ.
    Cancer; 2004 Oct 15; 101(8):1809-17. PubMed ID: 15386309
    [Abstract] [Full Text] [Related]

  • 8. Influence of stage classification, tumor differentiation and mode of invasion against clinical and histopathological effects on low dose sequential methotrexate and 5-fluorouracil administration as neo-adjuvant chemotherapy for oral squamous cell carcinoma.
    Asaumi J.
    In Vivo; 1997 Oct 15; 11(2):147-51. PubMed ID: 9179607
    [Abstract] [Full Text] [Related]

  • 9. Effectiveness of superselective and selective neck dissection for advanced nodal metastases after chemoradiation.
    Robbins KT, Doweck I, Samant S, Vieira F.
    Arch Otolaryngol Head Neck Surg; 2005 Nov 15; 131(11):965-9. PubMed ID: 16301367
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Response to intraarterial induction chemotherapy: a prognostic parameter in oral and oropharyngeal cancer.
    Kovács AF.
    Head Neck; 2006 Aug 15; 28(8):678-88. PubMed ID: 16721739
    [Abstract] [Full Text] [Related]

  • 12. [Clinical trial of chemotherapy by superselective intra-arterial infusion of nedaplatin combined with radiotherapy for advanced oral cancer].
    Yamshita Y, Shikimori M, Goto M.
    Gan To Kagaku Ryoho; 2005 Sep 15; 32(9):1267-71. PubMed ID: 16184922
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy followed by concurrent hyperfractionated radiation therapy and sensitizing chemotherapy for locally advanced (T3-T4) oropharyngeal squamous cell carcinoma.
    Finnegan V, Parsons JT, Greene BD, Sharma V.
    Head Neck; 2009 Feb 15; 31(2):167-74. PubMed ID: 18853443
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.
    Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.
    Eur J Cardiothorac Surg; 2008 May 15; 33(5):829-36. PubMed ID: 18367406
    [Abstract] [Full Text] [Related]

  • 19. Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.
    Shiga K, Yokoyama J, Hashimoto S, Saijo S, Tateda M, Ogawa T, Watanabe M, Kobayashi T.
    Otolaryngol Head Neck Surg; 2007 Jun 15; 136(6):1003-9. PubMed ID: 17547996
    [Abstract] [Full Text] [Related]

  • 20. Survival in squamous cell carcinoma of the oral cavity: differences between pT4 N0 and other stage IVA categories.
    Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC.
    Cancer; 2007 Aug 01; 110(3):564-71. PubMed ID: 17577219
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.